Keen to bag the latest NIB dividend? Time is running out

ASX investors will have to be quick if they want to secure NIB's latest dividend…

| More on:
A woman has a thoughtful look on her face as she studies a fan of Australian 20 dollar bills she is holding on one hand while he rest her other hand on her chin in thought.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • NIB shares are having a tough day today
  • But the health insurance giant is set for another rough day next Monday
  • That's because NIB is scheduled to trade ex-dividend...

It's been a rather sad end to the trading week for the NIB Holdings Limited (ASX: NHF) share price so far this Friday. At the time of writing, NIB shares have endured a 0.99% drop to $8 a share.

That stands in contrast to the broader S&P/ASX 200 Index (ASX: XJO). The ASX 200 has currently banked a tentative gain of 0.08% to around 6,850 points.

It's unclear what is causing investors to have some trepidation about NIB shares as we end the trading week today. But there's one thing we know for sure. The NIB share price is set for another tough day next Monday.

How can we know this? Well, that's when NIB is scheduled to trade ex-dividend for its upcoming final dividend payment.

The NIB dividend is coming, but you'll have to be quick

NIB announced its full-year earnings report for FY22 last month. At the time, the health insurance giant declared a final dividend of 11 cents per share, fully franked. This was a 21.4% decline from the final dividend of 14 cents per share that the company paid out last year for FY21.

It will take NIB's full-year dividends for FY22 to 22 cents per share. That follows April's interim dividend that was also worth 11 cents per share.

Again, that's a drop from FY21's total of 24 cents per share.

But if investors want to receive this dividend, they will have to act quickly. Monday's ex-dividend date means that today is the last day an investor can buy NIB shares to become eligible for this upcoming dividend. From Monday, new shareholders will be cut off.

This is why we are almost certainly set to see NIB shares go backwards during Monday's session. No new investors will be eligible for the final dividend come Monday. As such, the value of this dividend will leave the NIB share price. That's what normally happens when an ASX share goes ex-dividend.

Investors (or those eligible, anyway) will then have to wait until 4 October to see the dividend hit their bank accounts. NIB is offering shareholders the option of participating in the company's dividend reinvestment plan (DRP) though.

So if any investors wish to receive new NIB shares in lieu of cash, they have until 7 September to make this known to the company.

At the current NIB share price, this ASX 200 insurance share has a market capitalisation of $3.67 billion, with a dividend yield of 2.75%.

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended NIB Holdings Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
Healthcare Shares

This ASX All Ords share is diving 18% as inflation pain draws blood

This healthcare company delivered a trading update at its annual general meeting today.

Read more »

Shot of a young scientist using a digital tablet while working in a lab.
Healthcare Shares

Up 427% this year, why today is a big day for Mesoblast shares

Why is everyone talking about Mesoblast shares on Friday?

Read more »

A man holds his hand under his chin as he concentrates on his laptop screen and reads about the ANZ share price
Healthcare Shares

Is this beaten-down ASX healthcare share a bargain buy now?

One expert has given their view on this stock.

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Healthcare Shares

3 ASX healthcare shares going gangbusters on Thursday

Investors are sending these ASX healthcare stocks soaring today. But why?

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Is it time to cash in on Sigma shares?

Shares have extended after the Chemist Warehouse merger.

Read more »

Person holding Australian dollar notes, symbolising dividends.
Healthcare Shares

Buy this ASX 200 share that is swimming in cash

Bell Potter sees potentially big returns on offer from this cashed-up stock.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Are CSL shares a buy after the biotech's FY25 forecasts?

Brokers continue to weigh in.

Read more »

Female pharmacist smiles with a digital tablet.
Healthcare Shares

Are Wesfarmers or Sigma shares a better buy in the pharmacy arena?

These two stocks are both leaders in the industry.

Read more »